Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horizon Oncology Center is a private U.S. community oncology practice and cancer treatment center based in Lafayette, Indiana. Founded in 2001 by medical oncologist Wael Harb, the organization provides medical oncology, hematology, infusion-based cancer treatment, supportive care, and access to clinical trials, including early-phase studies. The business appears to operate as a healthcare delivery organization rather than a drug developer, with its value proposition centered on specialized regional cancer care and research-site capabilities. Public sources indicate the company was acquired by Pharos Capital Partners in 2018, but it continues to operate as an active separate entity. Horizon Oncology Center has also been described as a launching platform for broader oncology management and research activities associated with Wael Harb, including Horizon Oncology Research and later Verdi Oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horizon Oncology Center.